Eli Lilly says next-generation weight loss drug clears crucial obesity trial
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
Eli Lilly says next-generation weight loss drug clears crucial obesity trial basliginda one cikan gelisme: The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.